Inventor
HITCHCOCK STEPHEN
US35 patents
⚠️ This page may combine multiple inventors who share the name “HITCHCOCK STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
16 patentsUS10561662B2Feb 18, 2020
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
TAKEDA PHARMACEUTICALS CO4 citations83
US10159677B2Dec 25, 2018
4-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
TAKEDA PHARMACEUTICALS CO7 citations83
US9770450B2Sep 26, 2017
4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139
TAKEDA PHARMACEUTICALS CO7 citations83
US9670229B2Jun 6, 2017
5-HT3 receptor antagonists
TAKEDA PHARMACEUTICALS CO3 citations83
US9556130B2Jan 31, 2017
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
TAKEDA PHARMACEUTICALS CO9 citations83
US11173161B2Nov 16, 2021
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
TAKEDA PHARMACEUTICALS CO2 citations72
US10179783B2Jan 15, 2019
Tetrahydropyridopyrazines as modulators of GPR6
TAKEDA PHARMACEUTICALS CO2 citations72
US9770452B2Sep 26, 2017
Quinoxaline derivatives as GPR6 modulators
TAKEDA PHARMACEUTICALS CO4 citations72
US10077266B2Sep 18, 2018
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
TAKEDA PHARMACEUTICALS CO1 citations62
US10738046B2Aug 11, 2020
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
TAKEDA PHARMACEUTICALS CO0 citations51
US10407443B2Sep 10, 2019
5-HT3 receptor antagonists
TAKEDA PHARMACEUTICALS CO0 citations51
US10406157B2Sep 10, 2019
Tetrahydropyridopyrazine modulators of GPR6
TAKEDA PHARMACEUTICALS CO0 citations51
US10273225B2Apr 30, 2019
Pyrazines as modulators of GPR6
TAKEDA PHARMACEUTICALS CO0 citations51
US10125145B2Nov 13, 2018
5-HT3 receptor antagonists
TAKEDA PHARMACEUTICALS CO0 citations51
US10000468B2Jun 19, 2018
Pyrazines as modulators of GPR6
TAKEDA PHARMACEUTICALS CO1 citations51
US9695195B2Jul 4, 2017
5-HT3 receptor antagonists
TAKEDA PHARMACEUTICALS CO0 citations51
AMGEN INC
6 patentsUS7538114B2May 26, 2009
Glycine transporter-1 inhibitors
AMGEN INC14 citations91
US7989461B2Aug 2, 2011
Substituted quinazolinamine compounds for the treatment of cancer
AMGEN INC9 citations83
US7872009B2Jan 18, 2011
Beta-Secretase modulators and methods of use
AMGEN INC11 citations82
US7973047B2Jul 5, 2011
Beta-Secretase modulators and methods of use
AMGEN INC2 citations61
US7745484B2Jun 29, 2010
Beta-secretase modulators and methods of use
AMGEN INC2 citations60
US7838676B2Nov 23, 2010
Beta-secretase modulators and methods of use
AMGEN INC1 citations50
ZHONG WENGE
4 patentsUS8552181B2Oct 8, 2013
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8173810B2May 8, 2012
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8163909B2Apr 24, 2012
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations49
US8633315B2Jan 21, 2014
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
ZHONG WENGE0 citations46